Our read is that taking calcium is well supported for various health benefits, particularly bone health and oxalate management.
Our sources indicate that optimizing calcium intake is important for bone mineral density, especially for individuals with lower bone density or those in premenopausal/postmenopausal stages, as noted by Bryan Johnson.
Paul Saladino frequently highlights calcium's role in supporting colonic oxalate excretion and preventing bone loss, suggesting that many people are calcium deficient due to high oxalate consumption.
Peter Attia and Paul Saladino agree that bioavailable forms like calcium hydroxyapatite are effective, with Saladino emphasizing the superiority of microcrystalline hydroxyapatite complex over calcium carbonate for preventing bone loss.
To ensure adequate calcium intake, sources suggest consuming dietary sources like raw dairy, bone matrix, or bone meal. For supplementation, microcrystalline hydroxyapatite complex or calcium citrate are mentioned, with a specific note from Rhonda Patrick about a Swanson calcium/magnesium supplement (600mg calcium, 300mg magnesium). Eating bones, including those in bone broth or small animal bones, also provides bioavailable calcium. Balancing calcium and phosphorus intake is beneficial, especially with high-phosphorus diets from meat.
Paul Saladino warned that excessive calcium intake can trigger oxalate dumping, requiring careful adjustment based on tolerance, and that some individuals have experienced oxalate dumping and calcium oxalate kidney stones after stopping oxalate intake. He also noted that calcium from eggshells may contain fewer trace minerals and less lead compared to bone meal, but potentially more fluoride due to chickens drinking fluoridated water. Rhonda Patrick cautioned that excessive calcium intake can lead to magnesium deficiencies, and vice versa.
The verdict could change if new information emerged regarding the long-term safety or efficacy of specific calcium sources, or if further research contradicted the established benefits for bone health, oxalate management, or cancer risk reduction.
The intervention improves the primary outcome at standard doses in healthy adults.
Benefits hold across the populations where it's been tested.
Mechanistic and trial evidence converge on a real, replicable effect.
Calcium hydroxyapatite, found in bones, is bioavailable.
The intervention improves the primary outcome at standard doses in healthy adults.
Confounding and publication bias inflate the apparent benefit.
Animal-model results don't translate to the human protocol being recommended.
Most of the support comes from short or small studies.
The headline effect shrinks once you account for trial quality.
Confounding and publication bias inflate the apparent benefit.